Identification of neurodegenerative factors using translatome-regulatory network analysis

Nature Neuroscience

Volumn 18, Issue 9, 2015, Pages 1325-1333

  Brichta, Lars ^a   Shin, William ^b   Jackson Lewis, Vernice ^b,c   Blesa, Javier ^b,c   Yap, Ee Lynn ^a   Walker, Zachary ^a   Zhang, Jack ^a   Roussarie, Jean Pierre ^a   Alvarez, Mariano J ^b   Califano, Andrea ^b   Przedborski, Serge ^b,c   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Howard Hughes Medical Institute   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; REGULATOR PROTEIN; SATB1 PROTEIN; UNCLASSIFIED DRUG; ZDHHC2 PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN FUNCTION; CELL SPECIFICITY; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC ALGORITHM; GENETIC ASSOCIATION; MALE; MASTER REGULATOR INFERENCE ALGORITHM; MESENCEPHALON; MOLECULAR LIBRARY; MOUSE; MPTP-INDUCED PARKINSONISM; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SUBSTANTIA NIGRA PARS COMPACTA; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; GENETICS; METABOLISM; NERVE CELL NETWORK; PATHOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

ANIMALS; DOPAMINERGIC NEURONS; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE NET; NEURODEGENERATIVE DISEASES; PROTEIN BIOSYNTHESIS; SUBSTANTIA NIGRA;

EID: 84940461900     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4070     Document Type: Article

References (59)

1. Heiman, M. et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135, 738-748 (2008).
2. Doyle, J. P. et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135, 749-762 (2008).
3. Sanz, E. et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl. Acad. Sci. USA 106, 13939-13944 (2009).
4. Kanehisa, M. A database for post-genome analysis. Trends Genet. 13, 375-376 (1997).
5. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of largelists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
6. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
7. Carter, R. J., Morton, J. & Dunnett, S. B. Motor coordination and balance in rodents. Curr. Protoc. Neurosci. Ch. 8, Unit 8. 12 (2001).
8. Dauer, W. & Przedborski, S. Parkinsons disease: mechanisms and models. Neuron 39, 889-909 (2003).
9. Jackson-Lewis, V. & Przedborski, S. Protocol for the MPTP mouse model of Parkinsons disease. Nat. Protoc. 2, 141-151 (2007).
10. Jackson-Lewis, V., Blesa, J. & Przedborski, S. Animal models of Parkinsons disease. Parkinsonism Relat. Disord. 18 (suppl. 1): S183-S185 (2012).
11. Vila, M. et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinsons disease. Proc. Natl. Acad. Sci. USA 98, 2837-2842 (2001).
12. Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinsons disease. Brain 122, 1437-1448 (1999).
13. Hirsch, E., Graybiel, A. M. & Agid, Y. A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinsons disease. Nature 334, 345-348 (1988).
14. Jackson-Lewis, V., Jakowec, M., Burke, R. E. & Przedborski, S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Neurodegeneration 4, 257-269 (1995).
15. Muthane, U. et al. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in C57/bl and CD-1 mice. Exp. Neurol. 126, 195-204 (1994).
16. Bowenkamp, K. E. et al. 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor. Exp. Brain Res. 111, 1-7 (1996).
17. Piovan, E. et al. Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. Cancer Cell 24, 766-776 (2013).
18. Lefebvre, C. et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol. Syst. Biol. 6, 377 (2010).
19. Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325 (2010).
20. Aytes, A. et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell 25, 638-651 (2014).
21. Margolin, A. A. et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7 (suppl. 1): S7 (2006).
22. Chen, J. C. et al. Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks. Cell 159, 402-414 (2014).
23. Repunte-Canonigo, V. et al. Identifying candidate drivers of alcohol dependence-induced excessive drinking by assembly and interrogation of brain-specific regulatory networks. Genome Biol. 16, 68 (2015).
24. Aubry, S. et al. Assembly and interrogation of Alzheimers disease genetic networks reveal novel regulators of progression. PLoS ONE 10, e0120352 (2015).
25. Chung, C. Y. et al. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet. 14, 1709-1725 (2005).
26. Huang, Y. et al. Distribution of Satb1 in the central nervous system of adult mice. Neurosci. Res. 71, 12-21 (2011).
27. Close, J. et al. Satb1 is an activity-modulated transcription factor required for the terminal differentiation and connectivity of medial ganglionic eminence-derived cortical interneurons. J. Neurosci. 32, 17690-17705 (2012).
28. Zheng, B. et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinsons disease. Sci. Transl. Med. 2, 52ra73 (2010).
29. Grimm, J., Mueller, A., Hefti, F. & Rosenthal, A. Molecular basis for catecholaminergic neuron diversity. Proc. Natl. Acad. Sci. USA 101, 13891-13896 (2004).
30. Greene, J. G., Dingledine, R. & Greenamyre, J. T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis. 18, 19-31 (2005).
31. Phani, S., Gonye, G. & Iacovitti, L. VTA neurons show a potentially protective transcriptional response to MPTP. Brain Res. 1343, 1-13 (2010).
32. Greene, J. G., Dingledine, R. & Greenamyre, J. T. Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents. Neurobiol. Dis. 38, 476-481 (2010).
33. Miller, R. M. et al. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Exp. Neurol. 204, 421-432 (2007).
34. Bifsha, P., Yang, J., Fisher, R. A. & Drouin, J. Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra. PLoS Genet. 10, e1004863 (2014).
35. Ryan, S. D. et al. Isogenic human iPSC Parkinsons model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351-1364 (2013).
36. Okamoto, S., Krainc, D., Sherman, K. & Lipton, S. A. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl. Acad. Sci. USA 97, 7561-7566 (2000).
37. Cho, E. G. et al. MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model. PLoS ONE 6, e24027 (2011).
38. Gantz, S. C., Ford, C. P., Neve, K. A. & Williams, J. T. Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J. Neurosci. 31, 12629-12637 (2011).
39. Panayotis, N. et al. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse. Neurobiol. Dis. 41, 385-397 (2011).
40. Chan, C. S. et al. 'Rejuvenation' protects neurons in mouse models of Parkinsons disease. Nature 447, 1081-1086 (2007).
41. Guzman, J. N. et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696-700 (2010).
42. Mosharov, E. V. et al. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62, 218-229 (2009).
43. Yasui, D., Miyano, M., Cai, S., Varga-Weisz, P. & Kohwi-Shigematsu, T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419, 641-645 (2002).
44. Roth, A. F. et al. Global analysis of protein palmitoylation in yeast. Cell 125, 1003-1013 (2006).
45. Kostiuk, M. A., Keller, B. O. & Berthiaume, L. G. Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPARalpha and transcription at the Hmgcs2 PPRE. FASEB J. 24, 1914-1924 (2010).
46. Wang, K. et al. Genome-wide identification of post-translational modulators of transcription factor activity in human B cells. Nat. Biotechnol. 27, 829-839 (2009).
47. Gong, S. et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425, 917-925 (2003).
48. Heiman, M., Kulicke, R., Fenster, R. J., Greengard, P. & Heintz, N. Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP). Nat. Protoc. 9, 1282-1291 (2014).
49. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
50. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
51. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
52. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
53. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
54. Liberatore, G. T. et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403-1409 (1999).
55. Przedborski, S. et al. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93, 4565-4571 (1996).
56. Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25-29 (2000).
57. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
58. Brown, R. E. & Wong, A. A. The influence of visual ability on learning and memory performance in 13 strains of mice. Learn. Mem. 14, 134-144 (2007).
59. McFadyen, M. P., Kusek, G., Bolivar, V. J. & Flaherty, L. Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod. Genes Brain Behav. 2, 214-219 (2003).